Kosiborod MN, Deanfield J, Pratley R, Borlaug BA, Butler J, Davies MJ, Emerson SS, Kahn SE, Kitzman DW, Lingvay I, Mahaffey KW, Petrie MC, Plutzky J, Rasmussen S, Rnnbck C, Shah SJ, Verma S, Weeke PE, Lincoff AM, SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM Trial Committees and Investigators (2024) Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
While knee OA has traditionally been considered a degenerative disease, advancements in regenerative medicine are breaking new ground, halting and even reversing cartilage erosion, and giving new hope to knee OA sufferers
Many people can as long as its done and not too often
The extensiveness of their overall health benefits has made them one of the primary therapeutic choices for T2DM patients